Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer
Paul J FitzgeraldThe Zanvyl Krieger Mind/Brain Institute, Solomon H. Snyder, Department of Neuroscience, Johns Hopkins University, Baltimore, MD, USAAbstract: Recently, I put forth the hypothesis that the signaling molecule, norepinephrine (NE), is an etiological factor in a number of types of cance...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-12-01
|
| Series: | Clinical Epidemiology |
| Online Access: | http://www.dovepress.com/testing-whether-drugs-that-weaken-norepinephrine-signaling-prevent-or--a3879 |